Leukemia epigenetics in focus

(Wiley) Some severe forms of leukemia develop because proteins on the epigenetic level lose their regulative function. Now, in a broad international collaboration, UK researchers have identified molecules that can effectively inhibit the dysregulated proteins. In the journal Angewandte Chemie, researchers report the discovery, design, and testing of potential drugs on the cellular level. The findings set the stage for new biological experiments and cancer treatment approaches in the future.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news